Global Noninvasive Delivery Vaccine Production, Demand and Key Producers, 2022-2028
Noninvasive vaccine delivery systems need to incorporate an effective adjuvant, specially designed for triggering both mucosal and systemic immune responses.
This report studies the global Noninvasive Delivery Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Noninvasive Delivery Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Noninvasive Delivery Vaccine that contribute to its increasing demand across many markets.
The global Noninvasive Delivery Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Noninvasive Delivery Vaccine total production and demand, 2017-2028, (Units)
Global Noninvasive Delivery Vaccine total production value, 2017-2028, (USD Million)
Global Noninvasive Delivery Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Units)
Global Noninvasive Delivery Vaccine consumption by region & country, CAGR, 2017-2028 & (Units)
U.S. VS China: Noninvasive Delivery Vaccine domestic production, consumption, key domestic manufacturers and share
Global Noninvasive Delivery Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Units)
Global Noninvasive Delivery Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (Units)
Global Noninvasive Delivery Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (Units)
This reports profiles key players in the global Noninvasive Delivery Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Noninvasive Delivery Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Noninvasive Delivery Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Noninvasive Delivery Vaccine Market, By Region:
1. How big is the global Noninvasive Delivery Vaccine market?
2. What is the demand of the global Noninvasive Delivery Vaccine market?
3. What is the year over year growth of the global Noninvasive Delivery Vaccine market?
4. What is the production and production value of the global Noninvasive Delivery Vaccine market?
5. Who are the key producers in the global Noninvasive Delivery Vaccine market?
6. What are the growth factors driving the market demand?
This report studies the global Noninvasive Delivery Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Noninvasive Delivery Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Noninvasive Delivery Vaccine that contribute to its increasing demand across many markets.
The global Noninvasive Delivery Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Noninvasive Delivery Vaccine total production and demand, 2017-2028, (Units)
Global Noninvasive Delivery Vaccine total production value, 2017-2028, (USD Million)
Global Noninvasive Delivery Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Units)
Global Noninvasive Delivery Vaccine consumption by region & country, CAGR, 2017-2028 & (Units)
U.S. VS China: Noninvasive Delivery Vaccine domestic production, consumption, key domestic manufacturers and share
Global Noninvasive Delivery Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Units)
Global Noninvasive Delivery Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (Units)
Global Noninvasive Delivery Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (Units)
This reports profiles key players in the global Noninvasive Delivery Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Noninvasive Delivery Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Noninvasive Delivery Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Noninvasive Delivery Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Oral Vaccine
- Nasal Spray Vaccine
- Public
- Private
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- AstraZeneca
- Cipla
- BCHT
1. How big is the global Noninvasive Delivery Vaccine market?
2. What is the demand of the global Noninvasive Delivery Vaccine market?
3. What is the year over year growth of the global Noninvasive Delivery Vaccine market?
4. What is the production and production value of the global Noninvasive Delivery Vaccine market?
5. Who are the key producers in the global Noninvasive Delivery Vaccine market?
6. What are the growth factors driving the market demand?
'@LOT1 SUPPLY SUMMARY
1.1 Noninvasive Delivery Vaccine Introduction
1.2 World Noninvasive Delivery Vaccine Supply & Forecast
1.2.1 World Noninvasive Delivery Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Noninvasive Delivery Vaccine Production (2017-2028)
1.2.3 World Noninvasive Delivery Vaccine Pricing Trends (2017-2028)
1.3 World Noninvasive Delivery Vaccine Production by Region
1.3.1 World Noninvasive Delivery Vaccine Production Value by Region (2017-2028)
1.3.2 World Noninvasive Delivery Vaccine Production by Region (2017-2028)
1.3.3 World Noninvasive Delivery Vaccine Average Price by Region (2017-2028)
1.3.4 North America Noninvasive Delivery Vaccine Production (2017-2028)
1.3.5 Europe Noninvasive Delivery Vaccine Production (2017-2028)
1.3.6 China Noninvasive Delivery Vaccine Production (2017-2028)
1.3.7 Japan Noninvasive Delivery Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Noninvasive Delivery Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Noninvasive Delivery Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Noninvasive Delivery Vaccine Demand (2017-2028)
2.2 World Noninvasive Delivery Vaccine Consumption by Region
2.2.1 World Noninvasive Delivery Vaccine Consumption by Region (2017-2022)
2.2.2 World Noninvasive Delivery Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Noninvasive Delivery Vaccine Consumption (2017-2028)
2.4 China Noninvasive Delivery Vaccine Consumption (2017-2028)
2.5 Europe Noninvasive Delivery Vaccine Consumption (2017-2028)
2.6 Japan Noninvasive Delivery Vaccine Consumption (2017-2028)
2.7 South Korea Noninvasive Delivery Vaccine Consumption (2017-2028)
2.8 ASEAN Noninvasive Delivery Vaccine Consumption (2017-2028)
2.9 India Noninvasive Delivery Vaccine Consumption (2017-2028)
3 WORLD NONINVASIVE DELIVERY VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Noninvasive Delivery Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Noninvasive Delivery Vaccine Production by Manufacturer (2017-2022)
3.3 World Noninvasive Delivery Vaccine Average Price by Manufacturer (2017-2022)
3.4 Noninvasive Delivery Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Noninvasive Delivery Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Noninvasive Delivery Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Noninvasive Delivery Vaccine in 2021
3.6 Noninvasive Delivery Vaccine Market: Overall Company Footprint Analysis
3.6.1 Noninvasive Delivery Vaccine Market: Region Footprint
3.6.2 Noninvasive Delivery Vaccine Market: Company Product Type Footprint
3.6.3 Noninvasive Delivery Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Noninvasive Delivery Vaccine Production Value Comparison
4.1.1 United States VS China: Noninvasive Delivery Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Noninvasive Delivery Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Noninvasive Delivery Vaccine Production Comparison
4.2.1 United States VS China: Noninvasive Delivery Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Noninvasive Delivery Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Noninvasive Delivery Vaccine Consumption Comparison
4.3.1 United States VS China: Noninvasive Delivery Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Noninvasive Delivery Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Noninvasive Delivery Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Noninvasive Delivery Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Noninvasive Delivery Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Noninvasive Delivery Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Noninvasive Delivery Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Noninvasive Delivery Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Noninvasive Delivery Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Noninvasive Delivery Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Noninvasive Delivery Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Noninvasive Delivery Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Noninvasive Delivery Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Noninvasive Delivery Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Noninvasive Delivery Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Oral Vaccine
5.2.2 Nasal Spray Vaccine
5.3 Market Segment by Type
5.3.1 World Noninvasive Delivery Vaccine Production by Type (2017-2028)
5.3.2 World Noninvasive Delivery Vaccine Production Value by Type (2017-2028)
5.3.3 World Noninvasive Delivery Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Noninvasive Delivery Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Public
6.2.2 Private
6.3 Market Segment by Application
6.3.1 World Noninvasive Delivery Vaccine Production by Application (2017-2028)
6.3.2 World Noninvasive Delivery Vaccine Production Value by Application (2017-2028)
6.3.3 World Noninvasive Delivery Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Noninvasive Delivery Vaccine Product and Services
7.1.4 Merck Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK Noninvasive Delivery Vaccine Product and Services
7.2.4 GSK Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Sanofi
7.3.1 Sanofi Details
7.3.2 Sanofi Major Business
7.3.3 Sanofi Noninvasive Delivery Vaccine Product and Services
7.3.4 Sanofi Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Sanofi Recent Developments/Updates
7.3.6 Sanofi Competitive Strengths & Weaknesses
7.4 Lanzhou Institute
7.4.1 Lanzhou Institute Details
7.4.2 Lanzhou Institute Major Business
7.4.3 Lanzhou Institute Noninvasive Delivery Vaccine Product and Services
7.4.4 Lanzhou Institute Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Lanzhou Institute Recent Developments/Updates
7.4.6 Lanzhou Institute Competitive Strengths & Weaknesses
7.5 Serum Institute
7.5.1 Serum Institute Details
7.5.2 Serum Institute Major Business
7.5.3 Serum Institute Noninvasive Delivery Vaccine Product and Services
7.5.4 Serum Institute Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Serum Institute Recent Developments/Updates
7.5.6 Serum Institute Competitive Strengths & Weaknesses
7.6 Valneva
7.6.1 Valneva Details
7.6.2 Valneva Major Business
7.6.3 Valneva Noninvasive Delivery Vaccine Product and Services
7.6.4 Valneva Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Valneva Recent Developments/Updates
7.6.6 Valneva Competitive Strengths & Weaknesses
7.7 Shanghai United Cell
7.7.1 Shanghai United Cell Details
7.7.2 Shanghai United Cell Major Business
7.7.3 Shanghai United Cell Noninvasive Delivery Vaccine Product and Services
7.7.4 Shanghai United Cell Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Shanghai United Cell Recent Developments/Updates
7.7.6 Shanghai United Cell Competitive Strengths & Weaknesses
7.8 Bibcol
7.8.1 Bibcol Details
7.8.2 Bibcol Major Business
7.8.3 Bibcol Noninvasive Delivery Vaccine Product and Services
7.8.4 Bibcol Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Bibcol Recent Developments/Updates
7.8.6 Bibcol Competitive Strengths & Weaknesses
7.9 PaxVax
7.9.1 PaxVax Details
7.9.2 PaxVax Major Business
7.9.3 PaxVax Noninvasive Delivery Vaccine Product and Services
7.9.4 PaxVax Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 PaxVax Recent Developments/Updates
7.9.6 PaxVax Competitive Strengths & Weaknesses
7.10 Vabiotech
7.10.1 Vabiotech Details
7.10.2 Vabiotech Major Business
7.10.3 Vabiotech Noninvasive Delivery Vaccine Product and Services
7.10.4 Vabiotech Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Vabiotech Recent Developments/Updates
7.10.6 Vabiotech Competitive Strengths & Weaknesses
7.11 Tiantan Biological
7.11.1 Tiantan Biological Details
7.11.2 Tiantan Biological Major Business
7.11.3 Tiantan Biological Noninvasive Delivery Vaccine Product and Services
7.11.4 Tiantan Biological Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Tiantan Biological Recent Developments/Updates
7.11.6 Tiantan Biological Competitive Strengths & Weaknesses
7.12 EuBiologics
7.12.1 EuBiologics Details
7.12.2 EuBiologics Major Business
7.12.3 EuBiologics Noninvasive Delivery Vaccine Product and Services
7.12.4 EuBiologics Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 EuBiologics Recent Developments/Updates
7.12.6 EuBiologics Competitive Strengths & Weaknesses
7.13 Panacea Biotec Ltd
7.13.1 Panacea Biotec Ltd Details
7.13.2 Panacea Biotec Ltd Major Business
7.13.3 Panacea Biotec Ltd Noninvasive Delivery Vaccine Product and Services
7.13.4 Panacea Biotec Ltd Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Panacea Biotec Ltd Recent Developments/Updates
7.13.6 Panacea Biotec Ltd Competitive Strengths & Weaknesses
7.14 Bio-Med
7.14.1 Bio-Med Details
7.14.2 Bio-Med Major Business
7.14.3 Bio-Med Noninvasive Delivery Vaccine Product and Services
7.14.4 Bio-Med Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Bio-Med Recent Developments/Updates
7.14.6 Bio-Med Competitive Strengths & Weaknesses
7.15 Halfkin Bio-Pharmaceuticals
7.15.1 Halfkin Bio-Pharmaceuticals Details
7.15.2 Halfkin Bio-Pharmaceuticals Major Business
7.15.3 Halfkin Bio-Pharmaceuticals Noninvasive Delivery Vaccine Product and Services
7.15.4 Halfkin Bio-Pharmaceuticals Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7.15.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
7.16 AstraZeneca
7.16.1 AstraZeneca Details
7.16.2 AstraZeneca Major Business
7.16.3 AstraZeneca Noninvasive Delivery Vaccine Product and Services
7.16.4 AstraZeneca Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 AstraZeneca Recent Developments/Updates
7.16.6 AstraZeneca Competitive Strengths & Weaknesses
7.17 Cipla
7.17.1 Cipla Details
7.17.2 Cipla Major Business
7.17.3 Cipla Noninvasive Delivery Vaccine Product and Services
7.17.4 Cipla Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Cipla Recent Developments/Updates
7.17.6 Cipla Competitive Strengths & Weaknesses
7.18 BCHT
7.18.1 BCHT Details
7.18.2 BCHT Major Business
7.18.3 BCHT Noninvasive Delivery Vaccine Product and Services
7.18.4 BCHT Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 BCHT Recent Developments/Updates
7.18.6 BCHT Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Noninvasive Delivery Vaccine and Key Manufacturers
8.2 Noninvasive Delivery Vaccine Manufacturing Costs
8.3 Noninvasive Delivery Vaccine Production Process
8.4 Noninvasive Delivery Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Noninvasive Delivery Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Noninvasive Delivery Vaccine Typical Distributors
9.3 Noninvasive Delivery Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Noninvasive Delivery Vaccine Introduction
1.2 World Noninvasive Delivery Vaccine Supply & Forecast
1.2.1 World Noninvasive Delivery Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Noninvasive Delivery Vaccine Production (2017-2028)
1.2.3 World Noninvasive Delivery Vaccine Pricing Trends (2017-2028)
1.3 World Noninvasive Delivery Vaccine Production by Region
1.3.1 World Noninvasive Delivery Vaccine Production Value by Region (2017-2028)
1.3.2 World Noninvasive Delivery Vaccine Production by Region (2017-2028)
1.3.3 World Noninvasive Delivery Vaccine Average Price by Region (2017-2028)
1.3.4 North America Noninvasive Delivery Vaccine Production (2017-2028)
1.3.5 Europe Noninvasive Delivery Vaccine Production (2017-2028)
1.3.6 China Noninvasive Delivery Vaccine Production (2017-2028)
1.3.7 Japan Noninvasive Delivery Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Noninvasive Delivery Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Noninvasive Delivery Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Noninvasive Delivery Vaccine Demand (2017-2028)
2.2 World Noninvasive Delivery Vaccine Consumption by Region
2.2.1 World Noninvasive Delivery Vaccine Consumption by Region (2017-2022)
2.2.2 World Noninvasive Delivery Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Noninvasive Delivery Vaccine Consumption (2017-2028)
2.4 China Noninvasive Delivery Vaccine Consumption (2017-2028)
2.5 Europe Noninvasive Delivery Vaccine Consumption (2017-2028)
2.6 Japan Noninvasive Delivery Vaccine Consumption (2017-2028)
2.7 South Korea Noninvasive Delivery Vaccine Consumption (2017-2028)
2.8 ASEAN Noninvasive Delivery Vaccine Consumption (2017-2028)
2.9 India Noninvasive Delivery Vaccine Consumption (2017-2028)
3 WORLD NONINVASIVE DELIVERY VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Noninvasive Delivery Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Noninvasive Delivery Vaccine Production by Manufacturer (2017-2022)
3.3 World Noninvasive Delivery Vaccine Average Price by Manufacturer (2017-2022)
3.4 Noninvasive Delivery Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Noninvasive Delivery Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Noninvasive Delivery Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Noninvasive Delivery Vaccine in 2021
3.6 Noninvasive Delivery Vaccine Market: Overall Company Footprint Analysis
3.6.1 Noninvasive Delivery Vaccine Market: Region Footprint
3.6.2 Noninvasive Delivery Vaccine Market: Company Product Type Footprint
3.6.3 Noninvasive Delivery Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Noninvasive Delivery Vaccine Production Value Comparison
4.1.1 United States VS China: Noninvasive Delivery Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Noninvasive Delivery Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Noninvasive Delivery Vaccine Production Comparison
4.2.1 United States VS China: Noninvasive Delivery Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Noninvasive Delivery Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Noninvasive Delivery Vaccine Consumption Comparison
4.3.1 United States VS China: Noninvasive Delivery Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Noninvasive Delivery Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Noninvasive Delivery Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Noninvasive Delivery Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Noninvasive Delivery Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Noninvasive Delivery Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Noninvasive Delivery Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Noninvasive Delivery Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Noninvasive Delivery Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Noninvasive Delivery Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Noninvasive Delivery Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Noninvasive Delivery Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Noninvasive Delivery Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Noninvasive Delivery Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Noninvasive Delivery Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Oral Vaccine
5.2.2 Nasal Spray Vaccine
5.3 Market Segment by Type
5.3.1 World Noninvasive Delivery Vaccine Production by Type (2017-2028)
5.3.2 World Noninvasive Delivery Vaccine Production Value by Type (2017-2028)
5.3.3 World Noninvasive Delivery Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Noninvasive Delivery Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Public
6.2.2 Private
6.3 Market Segment by Application
6.3.1 World Noninvasive Delivery Vaccine Production by Application (2017-2028)
6.3.2 World Noninvasive Delivery Vaccine Production Value by Application (2017-2028)
6.3.3 World Noninvasive Delivery Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Noninvasive Delivery Vaccine Product and Services
7.1.4 Merck Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK Noninvasive Delivery Vaccine Product and Services
7.2.4 GSK Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Sanofi
7.3.1 Sanofi Details
7.3.2 Sanofi Major Business
7.3.3 Sanofi Noninvasive Delivery Vaccine Product and Services
7.3.4 Sanofi Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Sanofi Recent Developments/Updates
7.3.6 Sanofi Competitive Strengths & Weaknesses
7.4 Lanzhou Institute
7.4.1 Lanzhou Institute Details
7.4.2 Lanzhou Institute Major Business
7.4.3 Lanzhou Institute Noninvasive Delivery Vaccine Product and Services
7.4.4 Lanzhou Institute Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Lanzhou Institute Recent Developments/Updates
7.4.6 Lanzhou Institute Competitive Strengths & Weaknesses
7.5 Serum Institute
7.5.1 Serum Institute Details
7.5.2 Serum Institute Major Business
7.5.3 Serum Institute Noninvasive Delivery Vaccine Product and Services
7.5.4 Serum Institute Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Serum Institute Recent Developments/Updates
7.5.6 Serum Institute Competitive Strengths & Weaknesses
7.6 Valneva
7.6.1 Valneva Details
7.6.2 Valneva Major Business
7.6.3 Valneva Noninvasive Delivery Vaccine Product and Services
7.6.4 Valneva Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Valneva Recent Developments/Updates
7.6.6 Valneva Competitive Strengths & Weaknesses
7.7 Shanghai United Cell
7.7.1 Shanghai United Cell Details
7.7.2 Shanghai United Cell Major Business
7.7.3 Shanghai United Cell Noninvasive Delivery Vaccine Product and Services
7.7.4 Shanghai United Cell Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Shanghai United Cell Recent Developments/Updates
7.7.6 Shanghai United Cell Competitive Strengths & Weaknesses
7.8 Bibcol
7.8.1 Bibcol Details
7.8.2 Bibcol Major Business
7.8.3 Bibcol Noninvasive Delivery Vaccine Product and Services
7.8.4 Bibcol Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Bibcol Recent Developments/Updates
7.8.6 Bibcol Competitive Strengths & Weaknesses
7.9 PaxVax
7.9.1 PaxVax Details
7.9.2 PaxVax Major Business
7.9.3 PaxVax Noninvasive Delivery Vaccine Product and Services
7.9.4 PaxVax Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 PaxVax Recent Developments/Updates
7.9.6 PaxVax Competitive Strengths & Weaknesses
7.10 Vabiotech
7.10.1 Vabiotech Details
7.10.2 Vabiotech Major Business
7.10.3 Vabiotech Noninvasive Delivery Vaccine Product and Services
7.10.4 Vabiotech Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Vabiotech Recent Developments/Updates
7.10.6 Vabiotech Competitive Strengths & Weaknesses
7.11 Tiantan Biological
7.11.1 Tiantan Biological Details
7.11.2 Tiantan Biological Major Business
7.11.3 Tiantan Biological Noninvasive Delivery Vaccine Product and Services
7.11.4 Tiantan Biological Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Tiantan Biological Recent Developments/Updates
7.11.6 Tiantan Biological Competitive Strengths & Weaknesses
7.12 EuBiologics
7.12.1 EuBiologics Details
7.12.2 EuBiologics Major Business
7.12.3 EuBiologics Noninvasive Delivery Vaccine Product and Services
7.12.4 EuBiologics Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 EuBiologics Recent Developments/Updates
7.12.6 EuBiologics Competitive Strengths & Weaknesses
7.13 Panacea Biotec Ltd
7.13.1 Panacea Biotec Ltd Details
7.13.2 Panacea Biotec Ltd Major Business
7.13.3 Panacea Biotec Ltd Noninvasive Delivery Vaccine Product and Services
7.13.4 Panacea Biotec Ltd Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Panacea Biotec Ltd Recent Developments/Updates
7.13.6 Panacea Biotec Ltd Competitive Strengths & Weaknesses
7.14 Bio-Med
7.14.1 Bio-Med Details
7.14.2 Bio-Med Major Business
7.14.3 Bio-Med Noninvasive Delivery Vaccine Product and Services
7.14.4 Bio-Med Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Bio-Med Recent Developments/Updates
7.14.6 Bio-Med Competitive Strengths & Weaknesses
7.15 Halfkin Bio-Pharmaceuticals
7.15.1 Halfkin Bio-Pharmaceuticals Details
7.15.2 Halfkin Bio-Pharmaceuticals Major Business
7.15.3 Halfkin Bio-Pharmaceuticals Noninvasive Delivery Vaccine Product and Services
7.15.4 Halfkin Bio-Pharmaceuticals Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7.15.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
7.16 AstraZeneca
7.16.1 AstraZeneca Details
7.16.2 AstraZeneca Major Business
7.16.3 AstraZeneca Noninvasive Delivery Vaccine Product and Services
7.16.4 AstraZeneca Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 AstraZeneca Recent Developments/Updates
7.16.6 AstraZeneca Competitive Strengths & Weaknesses
7.17 Cipla
7.17.1 Cipla Details
7.17.2 Cipla Major Business
7.17.3 Cipla Noninvasive Delivery Vaccine Product and Services
7.17.4 Cipla Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Cipla Recent Developments/Updates
7.17.6 Cipla Competitive Strengths & Weaknesses
7.18 BCHT
7.18.1 BCHT Details
7.18.2 BCHT Major Business
7.18.3 BCHT Noninvasive Delivery Vaccine Product and Services
7.18.4 BCHT Noninvasive Delivery Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 BCHT Recent Developments/Updates
7.18.6 BCHT Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Noninvasive Delivery Vaccine and Key Manufacturers
8.2 Noninvasive Delivery Vaccine Manufacturing Costs
8.3 Noninvasive Delivery Vaccine Production Process
8.4 Noninvasive Delivery Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Noninvasive Delivery Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Noninvasive Delivery Vaccine Typical Distributors
9.3 Noninvasive Delivery Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Noninvasive Delivery Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Noninvasive Delivery Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Noninvasive Delivery Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Noninvasive Delivery Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Noninvasive Delivery Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Noninvasive Delivery Vaccine Production by Region (2017-2022) & (Units)
Table 7. World Noninvasive Delivery Vaccine Production by Region (2023-2028) & (Units)
Table 8. World Noninvasive Delivery Vaccine Production Market Share by Region (2017-2022)
Table 9. World Noninvasive Delivery Vaccine Production Market Share by Region (2023-2028)
Table 10. World Noninvasive Delivery Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Noninvasive Delivery Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Noninvasive Delivery Vaccine Major Market Trends
Table 13. World Noninvasive Delivery Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Units)
Table 14. World Noninvasive Delivery Vaccine Consumption by Region (2017-2022) & (Units)
Table 15. World Noninvasive Delivery Vaccine Consumption Forecast by Region (2023-2028) & (Units)
Table 16. World Noninvasive Delivery Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Noninvasive Delivery Vaccine Producers in 2021
Table 18. World Noninvasive Delivery Vaccine Production by Manufacturer (2017-2022) & (Units)
Table 19. Production Market Share of Key Noninvasive Delivery Vaccine Producers in 2021
Table 20. World Noninvasive Delivery Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Noninvasive Delivery Vaccine Company Evaluation Quadrant
Table 22. World Noninvasive Delivery Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Noninvasive Delivery Vaccine Production Site of Key Manufacturer
Table 24. Noninvasive Delivery Vaccine Market: Company Product Type Footprint
Table 25. Noninvasive Delivery Vaccine Market: Company Product Application Footprint
Table 26. Noninvasive Delivery Vaccine Competitive Factors
Table 27. Noninvasive Delivery Vaccine New Entrant and Capacity Expansion Plans
Table 28. Noninvasive Delivery Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Noninvasive Delivery Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Noninvasive Delivery Vaccine Production Comparison, (2017 & 2021 & 2028) & (Units)
Table 31. United States VS China Noninvasive Delivery Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (Units)
Table 32. Major Manufacturer of Noninvasive Delivery Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Noninvasive Delivery Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Noninvasive Delivery Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Noninvasive Delivery Vaccine Production by Domestic Manufacturer, (2017-2022) & (Units)
Table 36. United States Noninvasive Delivery Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Noninvasive Delivery Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Noninvasive Delivery Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Noninvasive Delivery Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Noninvasive Delivery Vaccine Production by Domestic Manufacturer, (2017-2022) & (Units)
Table 41. China Noninvasive Delivery Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Noninvasive Delivery Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Noninvasive Delivery Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Noninvasive Delivery Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Noninvasive Delivery Vaccine Production by Domestic Manufacturer, (2017-2022) & (Units)
Table 46. Rest of World Noninvasive Delivery Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Noninvasive Delivery Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Noninvasive Delivery Vaccine Production by Type (2017-2022) & (Units)
Table 49. World Noninvasive Delivery Vaccine Production by Type (2023-2028) & (Units)
Table 50. World Noninvasive Delivery Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Noninvasive Delivery Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Noninvasive Delivery Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Noninvasive Delivery Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Noninvasive Delivery Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Noninvasive Delivery Vaccine Production by Application (2017-2022) & (Units)
Table 56. World Noninvasive Delivery Vaccine Production by Application (2023-2028) & (Units)
Table 57. World Noninvasive Delivery Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Noninvasive Delivery Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Noninvasive Delivery Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Noninvasive Delivery Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Noninvasive Delivery Vaccine Product and Services
Table 64. Merck Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK Noninvasive Delivery Vaccine Product and Services
Table 70. GSK Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi Noninvasive Delivery Vaccine Product and Services
Table 76. Sanofi Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Sanofi Recent Developments/Updates
Table 78. Sanofi Competitive Strengths & Weaknesses
Table 79. Lanzhou Institute Basic Information, Manufacturing Base and Competitors
Table 80. Lanzhou Institute Major Business
Table 81. Lanzhou Institute Noninvasive Delivery Vaccine Product and Services
Table 82. Lanzhou Institute Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Lanzhou Institute Recent Developments/Updates
Table 84. Lanzhou Institute Competitive Strengths & Weaknesses
Table 85. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 86. Serum Institute Major Business
Table 87. Serum Institute Noninvasive Delivery Vaccine Product and Services
Table 88. Serum Institute Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Serum Institute Recent Developments/Updates
Table 90. Serum Institute Competitive Strengths & Weaknesses
Table 91. Valneva Basic Information, Manufacturing Base and Competitors
Table 92. Valneva Major Business
Table 93. Valneva Noninvasive Delivery Vaccine Product and Services
Table 94. Valneva Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Valneva Recent Developments/Updates
Table 96. Valneva Competitive Strengths & Weaknesses
Table 97. Shanghai United Cell Basic Information, Manufacturing Base and Competitors
Table 98. Shanghai United Cell Major Business
Table 99. Shanghai United Cell Noninvasive Delivery Vaccine Product and Services
Table 100. Shanghai United Cell Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Shanghai United Cell Recent Developments/Updates
Table 102. Shanghai United Cell Competitive Strengths & Weaknesses
Table 103. Bibcol Basic Information, Manufacturing Base and Competitors
Table 104. Bibcol Major Business
Table 105. Bibcol Noninvasive Delivery Vaccine Product and Services
Table 106. Bibcol Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Bibcol Recent Developments/Updates
Table 108. Bibcol Competitive Strengths & Weaknesses
Table 109. PaxVax Basic Information, Manufacturing Base and Competitors
Table 110. PaxVax Major Business
Table 111. PaxVax Noninvasive Delivery Vaccine Product and Services
Table 112. PaxVax Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. PaxVax Recent Developments/Updates
Table 114. PaxVax Competitive Strengths & Weaknesses
Table 115. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 116. Vabiotech Major Business
Table 117. Vabiotech Noninvasive Delivery Vaccine Product and Services
Table 118. Vabiotech Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Vabiotech Recent Developments/Updates
Table 120. Vabiotech Competitive Strengths & Weaknesses
Table 121. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 122. Tiantan Biological Major Business
Table 123. Tiantan Biological Noninvasive Delivery Vaccine Product and Services
Table 124. Tiantan Biological Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Tiantan Biological Recent Developments/Updates
Table 126. Tiantan Biological Competitive Strengths & Weaknesses
Table 127. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 128. EuBiologics Major Business
Table 129. EuBiologics Noninvasive Delivery Vaccine Product and Services
Table 130. EuBiologics Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. EuBiologics Recent Developments/Updates
Table 132. EuBiologics Competitive Strengths & Weaknesses
Table 133. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Panacea Biotec Ltd Major Business
Table 135. Panacea Biotec Ltd Noninvasive Delivery Vaccine Product and Services
Table 136. Panacea Biotec Ltd Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Panacea Biotec Ltd Recent Developments/Updates
Table 138. Panacea Biotec Ltd Competitive Strengths & Weaknesses
Table 139. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 140. Bio-Med Major Business
Table 141. Bio-Med Noninvasive Delivery Vaccine Product and Services
Table 142. Bio-Med Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Bio-Med Recent Developments/Updates
Table 144. Bio-Med Competitive Strengths & Weaknesses
Table 145. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Halfkin Bio-Pharmaceuticals Major Business
Table 147. Halfkin Bio-Pharmaceuticals Noninvasive Delivery Vaccine Product and Services
Table 148. Halfkin Bio-Pharmaceuticals Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 150. Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
Table 151. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 152. AstraZeneca Major Business
Table 153. AstraZeneca Noninvasive Delivery Vaccine Product and Services
Table 154. AstraZeneca Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. AstraZeneca Recent Developments/Updates
Table 156. AstraZeneca Competitive Strengths & Weaknesses
Table 157. Cipla Basic Information, Manufacturing Base and Competitors
Table 158. Cipla Major Business
Table 159. Cipla Noninvasive Delivery Vaccine Product and Services
Table 160. Cipla Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Cipla Recent Developments/Updates
Table 162. BCHT Basic Information, Manufacturing Base and Competitors
Table 163. BCHT Major Business
Table 164. BCHT Noninvasive Delivery Vaccine Product and Services
Table 165. BCHT Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 166. Noninvasive Delivery Vaccine Raw Material
Table 167. Key Manufacturers of Noninvasive Delivery Vaccine Raw Materials
Table 168. Noninvasive Delivery Vaccine Typical Distributors
Table 169. Noninvasive Delivery Vaccine Typical Customers
Table 1. World Noninvasive Delivery Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Noninvasive Delivery Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Noninvasive Delivery Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Noninvasive Delivery Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Noninvasive Delivery Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Noninvasive Delivery Vaccine Production by Region (2017-2022) & (Units)
Table 7. World Noninvasive Delivery Vaccine Production by Region (2023-2028) & (Units)
Table 8. World Noninvasive Delivery Vaccine Production Market Share by Region (2017-2022)
Table 9. World Noninvasive Delivery Vaccine Production Market Share by Region (2023-2028)
Table 10. World Noninvasive Delivery Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Noninvasive Delivery Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Noninvasive Delivery Vaccine Major Market Trends
Table 13. World Noninvasive Delivery Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Units)
Table 14. World Noninvasive Delivery Vaccine Consumption by Region (2017-2022) & (Units)
Table 15. World Noninvasive Delivery Vaccine Consumption Forecast by Region (2023-2028) & (Units)
Table 16. World Noninvasive Delivery Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Noninvasive Delivery Vaccine Producers in 2021
Table 18. World Noninvasive Delivery Vaccine Production by Manufacturer (2017-2022) & (Units)
Table 19. Production Market Share of Key Noninvasive Delivery Vaccine Producers in 2021
Table 20. World Noninvasive Delivery Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Noninvasive Delivery Vaccine Company Evaluation Quadrant
Table 22. World Noninvasive Delivery Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Noninvasive Delivery Vaccine Production Site of Key Manufacturer
Table 24. Noninvasive Delivery Vaccine Market: Company Product Type Footprint
Table 25. Noninvasive Delivery Vaccine Market: Company Product Application Footprint
Table 26. Noninvasive Delivery Vaccine Competitive Factors
Table 27. Noninvasive Delivery Vaccine New Entrant and Capacity Expansion Plans
Table 28. Noninvasive Delivery Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Noninvasive Delivery Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Noninvasive Delivery Vaccine Production Comparison, (2017 & 2021 & 2028) & (Units)
Table 31. United States VS China Noninvasive Delivery Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (Units)
Table 32. Major Manufacturer of Noninvasive Delivery Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Noninvasive Delivery Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Noninvasive Delivery Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Noninvasive Delivery Vaccine Production by Domestic Manufacturer, (2017-2022) & (Units)
Table 36. United States Noninvasive Delivery Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Noninvasive Delivery Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Noninvasive Delivery Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Noninvasive Delivery Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Noninvasive Delivery Vaccine Production by Domestic Manufacturer, (2017-2022) & (Units)
Table 41. China Noninvasive Delivery Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Noninvasive Delivery Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Noninvasive Delivery Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Noninvasive Delivery Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Noninvasive Delivery Vaccine Production by Domestic Manufacturer, (2017-2022) & (Units)
Table 46. Rest of World Noninvasive Delivery Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Noninvasive Delivery Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Noninvasive Delivery Vaccine Production by Type (2017-2022) & (Units)
Table 49. World Noninvasive Delivery Vaccine Production by Type (2023-2028) & (Units)
Table 50. World Noninvasive Delivery Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Noninvasive Delivery Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Noninvasive Delivery Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Noninvasive Delivery Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Noninvasive Delivery Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Noninvasive Delivery Vaccine Production by Application (2017-2022) & (Units)
Table 56. World Noninvasive Delivery Vaccine Production by Application (2023-2028) & (Units)
Table 57. World Noninvasive Delivery Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Noninvasive Delivery Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Noninvasive Delivery Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Noninvasive Delivery Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Noninvasive Delivery Vaccine Product and Services
Table 64. Merck Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK Noninvasive Delivery Vaccine Product and Services
Table 70. GSK Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi Noninvasive Delivery Vaccine Product and Services
Table 76. Sanofi Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Sanofi Recent Developments/Updates
Table 78. Sanofi Competitive Strengths & Weaknesses
Table 79. Lanzhou Institute Basic Information, Manufacturing Base and Competitors
Table 80. Lanzhou Institute Major Business
Table 81. Lanzhou Institute Noninvasive Delivery Vaccine Product and Services
Table 82. Lanzhou Institute Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Lanzhou Institute Recent Developments/Updates
Table 84. Lanzhou Institute Competitive Strengths & Weaknesses
Table 85. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 86. Serum Institute Major Business
Table 87. Serum Institute Noninvasive Delivery Vaccine Product and Services
Table 88. Serum Institute Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Serum Institute Recent Developments/Updates
Table 90. Serum Institute Competitive Strengths & Weaknesses
Table 91. Valneva Basic Information, Manufacturing Base and Competitors
Table 92. Valneva Major Business
Table 93. Valneva Noninvasive Delivery Vaccine Product and Services
Table 94. Valneva Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Valneva Recent Developments/Updates
Table 96. Valneva Competitive Strengths & Weaknesses
Table 97. Shanghai United Cell Basic Information, Manufacturing Base and Competitors
Table 98. Shanghai United Cell Major Business
Table 99. Shanghai United Cell Noninvasive Delivery Vaccine Product and Services
Table 100. Shanghai United Cell Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Shanghai United Cell Recent Developments/Updates
Table 102. Shanghai United Cell Competitive Strengths & Weaknesses
Table 103. Bibcol Basic Information, Manufacturing Base and Competitors
Table 104. Bibcol Major Business
Table 105. Bibcol Noninvasive Delivery Vaccine Product and Services
Table 106. Bibcol Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Bibcol Recent Developments/Updates
Table 108. Bibcol Competitive Strengths & Weaknesses
Table 109. PaxVax Basic Information, Manufacturing Base and Competitors
Table 110. PaxVax Major Business
Table 111. PaxVax Noninvasive Delivery Vaccine Product and Services
Table 112. PaxVax Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. PaxVax Recent Developments/Updates
Table 114. PaxVax Competitive Strengths & Weaknesses
Table 115. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 116. Vabiotech Major Business
Table 117. Vabiotech Noninvasive Delivery Vaccine Product and Services
Table 118. Vabiotech Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Vabiotech Recent Developments/Updates
Table 120. Vabiotech Competitive Strengths & Weaknesses
Table 121. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 122. Tiantan Biological Major Business
Table 123. Tiantan Biological Noninvasive Delivery Vaccine Product and Services
Table 124. Tiantan Biological Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Tiantan Biological Recent Developments/Updates
Table 126. Tiantan Biological Competitive Strengths & Weaknesses
Table 127. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 128. EuBiologics Major Business
Table 129. EuBiologics Noninvasive Delivery Vaccine Product and Services
Table 130. EuBiologics Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. EuBiologics Recent Developments/Updates
Table 132. EuBiologics Competitive Strengths & Weaknesses
Table 133. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Panacea Biotec Ltd Major Business
Table 135. Panacea Biotec Ltd Noninvasive Delivery Vaccine Product and Services
Table 136. Panacea Biotec Ltd Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Panacea Biotec Ltd Recent Developments/Updates
Table 138. Panacea Biotec Ltd Competitive Strengths & Weaknesses
Table 139. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 140. Bio-Med Major Business
Table 141. Bio-Med Noninvasive Delivery Vaccine Product and Services
Table 142. Bio-Med Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Bio-Med Recent Developments/Updates
Table 144. Bio-Med Competitive Strengths & Weaknesses
Table 145. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Halfkin Bio-Pharmaceuticals Major Business
Table 147. Halfkin Bio-Pharmaceuticals Noninvasive Delivery Vaccine Product and Services
Table 148. Halfkin Bio-Pharmaceuticals Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 150. Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
Table 151. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 152. AstraZeneca Major Business
Table 153. AstraZeneca Noninvasive Delivery Vaccine Product and Services
Table 154. AstraZeneca Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. AstraZeneca Recent Developments/Updates
Table 156. AstraZeneca Competitive Strengths & Weaknesses
Table 157. Cipla Basic Information, Manufacturing Base and Competitors
Table 158. Cipla Major Business
Table 159. Cipla Noninvasive Delivery Vaccine Product and Services
Table 160. Cipla Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Cipla Recent Developments/Updates
Table 162. BCHT Basic Information, Manufacturing Base and Competitors
Table 163. BCHT Major Business
Table 164. BCHT Noninvasive Delivery Vaccine Product and Services
Table 165. BCHT Noninvasive Delivery Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 166. Noninvasive Delivery Vaccine Raw Material
Table 167. Key Manufacturers of Noninvasive Delivery Vaccine Raw Materials
Table 168. Noninvasive Delivery Vaccine Typical Distributors
Table 169. Noninvasive Delivery Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Noninvasive Delivery Vaccine Picture
Figure 2. World Noninvasive Delivery Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Noninvasive Delivery Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Noninvasive Delivery Vaccine Production (2017-2028) & (Units)
Figure 5. World Noninvasive Delivery Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Noninvasive Delivery Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Noninvasive Delivery Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Noninvasive Delivery Vaccine Production (2017-2028) & (Units)
Figure 9. Europe Noninvasive Delivery Vaccine Production (2017-2028) & (Units)
Figure 10. China Noninvasive Delivery Vaccine Production (2017-2028) & (Units)
Figure 11. Japan Noninvasive Delivery Vaccine Production (2017-2028) & (Units)
Figure 12. Noninvasive Delivery Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Noninvasive Delivery Vaccine Demand (2017-2028) & (Units)
Figure 15. World Noninvasive Delivery Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Noninvasive Delivery Vaccine Consumption (2017-2028) & (Units)
Figure 17. China Noninvasive Delivery Vaccine Consumption (2017-2028) & (Units)
Figure 18. Europe Noninvasive Delivery Vaccine Consumption (2017-2028) & (Units)
Figure 19. Japan Noninvasive Delivery Vaccine Consumption (2017-2028) & (Units)
Figure 20. South Korea Noninvasive Delivery Vaccine Consumption (2017-2028) & (Units)
Figure 21. ASEAN Noninvasive Delivery Vaccine Consumption (2017-2028) & (Units)
Figure 22. India Noninvasive Delivery Vaccine Consumption (2017-2028) & (Units)
Figure 23. Producer Shipments of Noninvasive Delivery Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Noninvasive Delivery Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Noninvasive Delivery Vaccine Markets in 2021
Figure 26. United States VS China: Noninvasive Delivery Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Noninvasive Delivery Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Noninvasive Delivery Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Noninvasive Delivery Vaccine in United States
Figure 30. Key Producers and Market Share of Noninvasive Delivery Vaccine in China
Figure 31. Key Producers and Market Share of Noninvasive Delivery Vaccine in Rest of World
Figure 32. World Noninvasive Delivery Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Noninvasive Delivery Vaccine Production Value Market Share by Type in 2021
Figure 34. Oral Vaccine
Figure 35. Nasal Spray Vaccine
Figure 36. World Noninvasive Delivery Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Noninvasive Delivery Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Noninvasive Delivery Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Noninvasive Delivery Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Noninvasive Delivery Vaccine Production Value Market Share by Application in 2021
Figure 41. Public
Figure 42. Private
Figure 43. World Noninvasive Delivery Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Noninvasive Delivery Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Noninvasive Delivery Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Noninvasive Delivery Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Noninvasive Delivery Vaccine
Figure 48. Noninvasive Delivery Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Noninvasive Delivery Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Noninvasive Delivery Vaccine Picture
Figure 2. World Noninvasive Delivery Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Noninvasive Delivery Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Noninvasive Delivery Vaccine Production (2017-2028) & (Units)
Figure 5. World Noninvasive Delivery Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Noninvasive Delivery Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Noninvasive Delivery Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Noninvasive Delivery Vaccine Production (2017-2028) & (Units)
Figure 9. Europe Noninvasive Delivery Vaccine Production (2017-2028) & (Units)
Figure 10. China Noninvasive Delivery Vaccine Production (2017-2028) & (Units)
Figure 11. Japan Noninvasive Delivery Vaccine Production (2017-2028) & (Units)
Figure 12. Noninvasive Delivery Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Noninvasive Delivery Vaccine Demand (2017-2028) & (Units)
Figure 15. World Noninvasive Delivery Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Noninvasive Delivery Vaccine Consumption (2017-2028) & (Units)
Figure 17. China Noninvasive Delivery Vaccine Consumption (2017-2028) & (Units)
Figure 18. Europe Noninvasive Delivery Vaccine Consumption (2017-2028) & (Units)
Figure 19. Japan Noninvasive Delivery Vaccine Consumption (2017-2028) & (Units)
Figure 20. South Korea Noninvasive Delivery Vaccine Consumption (2017-2028) & (Units)
Figure 21. ASEAN Noninvasive Delivery Vaccine Consumption (2017-2028) & (Units)
Figure 22. India Noninvasive Delivery Vaccine Consumption (2017-2028) & (Units)
Figure 23. Producer Shipments of Noninvasive Delivery Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Noninvasive Delivery Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Noninvasive Delivery Vaccine Markets in 2021
Figure 26. United States VS China: Noninvasive Delivery Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Noninvasive Delivery Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Noninvasive Delivery Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Noninvasive Delivery Vaccine in United States
Figure 30. Key Producers and Market Share of Noninvasive Delivery Vaccine in China
Figure 31. Key Producers and Market Share of Noninvasive Delivery Vaccine in Rest of World
Figure 32. World Noninvasive Delivery Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Noninvasive Delivery Vaccine Production Value Market Share by Type in 2021
Figure 34. Oral Vaccine
Figure 35. Nasal Spray Vaccine
Figure 36. World Noninvasive Delivery Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Noninvasive Delivery Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Noninvasive Delivery Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Noninvasive Delivery Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Noninvasive Delivery Vaccine Production Value Market Share by Application in 2021
Figure 41. Public
Figure 42. Private
Figure 43. World Noninvasive Delivery Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Noninvasive Delivery Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Noninvasive Delivery Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Noninvasive Delivery Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Noninvasive Delivery Vaccine
Figure 48. Noninvasive Delivery Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Noninvasive Delivery Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
